This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Intrauterine tranfusion, already obstetrics' newest and most daring procedure, is headed for "seemingly radical" changes to render it safer, a Detroit clinician believes.
Speaking before the section on obstetrics and gynecology, Bernard Mandelbaum, MD, said that:
Clinically, it now appears safe to allow a transfused fetus to progress practically to term delivery, and
Experimentally, a fiber optic amnioscope may allow direct visualization of the fetus with resulting changes in technique.
'Last Resort' Measure
From the beginning, intrauterine transfusion has been considered a "last resort" measure to maintain fetal viability until delivery can be induced (JAMAMedical News, 194:5 [Nov 1] 1965)."After two to three transfusions, the fetus often is no longer severely affected," said Dr. Mandelbaum. "Many of the transfused fetuses who appeared most severely ill by amniocentesis have proven Coombs' negative—Rh negative at birth." The infants' blood had been virtually replaced by donor red cells, continued Dr.
Intrauterine Transfusion—Headed For Change?. JAMA. 1966;197(1):A23–A24. doi:10.1001/jama.1966.03110010019005
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.